Bladder Cancer
Efficacy and Safety of Neoadjuvant Immunotherapy in Combination with Neoadjuvant Gemcitabine and Cisplatin - Expert Commentary
December 15, 2022
Sequential intravesical gemcitabine and docetaxel therapy in patients with nonmuscle invasive bladder cancer: a systematic review and meta-analysis.
December 15, 2022
Radical cystectomy and urinary diversion in women: techniques, outcomes, and challenges-a narrative review.
December 14, 2022
Downstaging and survival after Neoadjuvant chemotherapy for bladder cancer in Norway; a population-based study.
December 14, 2022
Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors.
December 14, 2022
Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological Subtype.
December 13, 2022
The cytidine deaminase APOBEC3G contributes to cancer mutagenesis and clonal evolution in bladder cancer.
December 12, 2022
Complications after neoadjuvant chemotherapy and radical cystectomy for patients with bladder cancer: A propensity score matched analysis.
December 9, 2022
Urine-Based Markers for Detection of Urothelial Cancer and for the Management of Non-muscle-Invasive Bladder Cancer.
December 9, 2022
A Deep Learning Model for Guiding Precision Therapy in Bladder Cancer - Expert Commentary
December 8, 2022
The effect of chemotherapy in sarcomatoid bladder cancer patients treated with radical cystectomy.
December 8, 2022
Artificial Intelligence Meets Whole Slide Images: Deep Learning Model Shapes an Immune-Hot Tumor and Guides Precision Therapy in Bladder Cancer.
December 8, 2022
Urothelial carcinoma of the bladder with isolated lymph node metastasis: Natural history and outcomes following surgical resection.
December 7, 2022
Global changes in bladder cancer mortality in the elderly.
December 7, 2022